Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial
Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision has been updated to version v3.6.5, indicating a small metadata update to the study record.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page now lists a new Data Protection Officer with contact details, while several previous contacts and investigators’ information were removed, reflecting a revision of how to reach the study team.SummaryDifference0.6%

- Check24 days agoChange DetectedThe page shows an updated revision tag, changing from v3.6.3 to v3.6.4, indicating a new site version without altering the study details.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision label on the page changed from v3.6.2 to v3.6.3, indicating a new page revision. This is a minor metadata update that does not alter the study content or data.SummaryDifference0.0%

- Check53 days agoChange DetectedThe revision label was updated from v3.6.0 to v3.6.2, indicating a new release of the page's versioning metadata. This change does not affect the visible content or user-facing features.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded new quick-access sections such as Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study, and the page revision tag updated to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.